1 蒋鹏,宋科官.破骨细胞及其分化调节机制的研究进展[J].中国骨与关节杂志,2017,6(3):223-227. 2 Cho YA,Jue SS,Bae WJ,et al.PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses[J].J Dent Res,2015,94(2):371. 3 Yao CH,Zhang P,Zhang L.Differential protein and mRNA expression of CaMKs during osteoclastogenesis and its functional implications[J].Can J Biochem Cell Biol,2012,90(4):532-539. 4 Weitzmann MN.Osteoclasts:malefactors of disease and targets for treatment[J].Discov Med,2012,13(70):201. 5 Si J,Collins SJ.Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation[J].Can Res Suppl,2008,68(10):3733-3742. 6 Hudmon A,Schulman H.Neuronal Ca2+/calmodulin-dependent protein kinase II:the role of structure and autoregulation in cellular function[J].Annu Rev Biochem,2002,71(1):473-510. 7 Wayman GA,Tokumitsu H,Davare MA,et al.Analysis of CaM-kinase signaling in cells[J].Cell Calcium,2011,50(1):1-8. 8 Sato K,Suematsu A,Nakashima T,et al.Regulation of osteoclast differentiation and function by the CaMK-CREB Pathway[J].Nat Med,2006,12(12):1410-1416. 9 陆大壮,刘娟娟,戚孟春,等.CaMKIIδ在破骨细胞分化不同阶段表达规律的研究[J].中国病理生理杂志,2016,32(10):1870-1874. 10 李瑛,戚孟春,董伟,等.CaMKⅡγ在破骨细胞分化中的表达规律[J].中南大学学报(医学版),2018,43(3):240-245. 11 Koga TN,Takayanagi H.Ca~(2+)-NFATc1 signaling is an essential axis of osteoclast differentiation[J].Immunol Rev,2010,231(1):241-256. 12 Seales EC,Micoli KJ,Mcdonald JM.Calmodulin is a critical regulator of osteoclastic differentiation,function,and survival[J].J Cell Biochem,2010,97(1):45-55. 13 阴露佳,林珏杉,温黎明,等.唑来膦酸对破骨细胞分化中钙调蛋白、钙调磷酸酶表达的影响[J].南京医科大学学报(自然科学版),2016,36(2):171-175. 14 Kanaseki T,Ikeuchi Y,Sugiura H,et al.Structural features of Ca2+/calmodulin-dependent protein kinase II revealed by electron microscopy[J].J Cell Biol,1991,115(4):1049-1060. 15 Park K,Park B,Yoon D,et al.Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway[J].Cell Commun Signal,2013,11(1):74. 16 王会,刘娟娟,戚孟春,等.唑来膦酸对破骨细胞分化中CaMKⅡδ及下游基因表达的影响[J].重庆医学,2017,46(10):1308-1311. 17 刘娟娟,董伟,戚孟春,等.钙离子/钙调蛋白依赖性蛋白激酶IIδ RNA干扰对下游基因表达及破骨细胞分化的影响[J].第三军医大学学报,2017,39(1):22-27. 18 Zhao Q,Wang X,Liu Y,et al.NFATc1:functions in osteoclasts[J].Int J Biochem Cell Biol,2010,42(5):576-579. 19 赵涛,郑升法,李刚,等.蛋白激酶C和酪氨酸激酶在机械通气相关肺损伤中的作用机制[J].中国医药,2018,13(4):537-540. 20 Ke K,Sul OJ,Choi EK,et al.Reactive oxygen species induce the association of SHP-1 with c-Src and the oxidation of both to enhance osteoclast survival[J].Am J Physiol Endocrinol Metab,2014,307(1):61. 21 Zhang J,Wang S,Jiang B,et al.c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis[J].Nat Commun,2017,8:13732. 22 Osorio-Fuentealba C,Klip A.Dissecting signalling by individual Akt/PKB isoforms,three steps at once[J].Biochem J,2015,470(2):13-16. 23 刘凤祥,朱振安.RANKL/RANK通路在破骨细胞活性调节及骨溶解中的作用[J].生物骨科材料与临床研究,2007,4(3):24-26. 24 马雪莹,杨巍,刘宁.骨桥蛋白与骨质疏松症研究进展[J].黑龙江科学,2011,2(1):40-43. 25 Ek-Rylander B,Andersson G.Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase[J].Exp Cell Res,2010,316(3):443-451. 26 任民柱,杨留勤.骨桥蛋白在肿瘤转移中的作用及机制[J].实用肿瘤学杂志,2010,24(2):186-189. |